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Background. It has recently been proposed that major depressive disorder 
(MDD) may, in a heterogeneous population-based cohort, be interpreted in 
terms of a random-mood model. Mood fluctuations are thought to result 
from stressors that occur randomly in time. We have investigated whether 
this concept also holds for more homogeneous groups, defined by known 
determinants for MDD, and whether the model‟s parameters, susceptibility 
(Z) and relaxation time (T), may be evaluated and used to differentiate 
between subcohorts.  
 
Method. From a large epidemiological survey, the Netherlands Mental 
Health Survey and Incidence Study (NEMESIS), data on the duration of 
MDD were obtained for subcohorts, based on gender, severity of 
depression, recurrence and co-morbidity with dysthymia, anxiety and 
somatic disorder, and were compared with random-mood simulation 
calculations. 
 
Results. Susceptibility, Z, is empirically found to be proportional to 
incidence and may be identified with a risk ratio. A second scaling rule 
states the proportionality of mean duration with the product of Z and T. This 
Z–T classification proves to be more sensitive than conventional  
significance tests. Notably for men/women and for co-morbid anxiety, 
differences are seen that have previously gone unnoticed. 
 
Conclusions. Depression may be conceptualized as a disorder resulting 
from random-mood fluctuations, the response to which is influenced by a 
large variety of determinants or risk factors. The model‟s parameters can be 
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Major depressive disorder (MDD) is a common and disabling illness with  
serious consequences for personal and public life.
1
 In many individuals it 





 that the time course of MDD may be modelled in terms 
of a random-mood model. In brief, mood is measured on a linear scale. The 
units need not be specified but for convenience we refer to them as munits. 
Mood is assumed to result as a response to stressor signals, which are as 
yet left unspecified but may be viewed as life events. These stressor  
signals, or stimuli, occur randomly in time. They can be either positive or 
negative and their magnitudes are random. Each individual has a different 
sensitivity to mood stimuli that is reflected in the model‟s susceptibility 
parameter, Z, which determines how strongly mood follows the imposed 
stimulus pattern. Between stimuli, mood is assumed to tend exponentially to 
zero with a relaxation time, T, which determines how long afterwards the 
stimulus is felt and how slowly or rapidly it dies out. Aside from this 
intermittent pattern of stimuli, there are daily mood fluctuations that do not 
change the essential features of the model. Figure 1 presents an 
impression of mood fluctuations as they might occur over a typical lifespan 
of 80 years. An MDD episode is taken as the time that mood stays below an 
adopted depression level (broken line in the figure), provided that, in line 
with the DSM inclusion criteria,
12
 that time is at least 2 weeks. There has 
been a tendency over the past decade to interpret individual self-recorded 
mood sequences in terms of chaos theory, which would suggest that the  
time development of mood might be deterministic.
13-15
 The random-mood 
model takes an opposite point of view and has been shown to be capable of 
reproducing the same mood-sequence characteristics.
11
 Its parameters, Z  
and T, may be looked upon as characteristic of individual subjects or  
groups of subjects. In the present work we attempt to adapt the random-
mood model as a tool of analysis and address the following questions: 
(1) Does this model also work for subgroups, defined along the lines of 
several known determinants for depression? 
(2) Is it possible to relate the model‟s parameters, Z and T, to quantities that 
are easily identified in daily life and/or in clinical practice? 
(3) How do contrasting subgroups differ in their values for these  
parameters?  
The data studied are newly originated MDD episodes in a random sample 
of the Dutch population from the Netherlands Mental Health Survey and 
Incidence Study (NEMESIS
8-10
). Within the follow-up time of 2 years, about 
80% of these subjects recover, their depressive fraction decreasing 
exponentially with a mean duration of approximately 4 months. After the 
initial 4 months, the full cohort‟s recovery rate slows down drastically (see 
also Keller et al.
2
). In our data, this later recovery rate was slow enough to 
make it practical to model the long-lasting fraction (≈20%) as constant over 
the follow-up time. Without suggesting that these subjects could never  
recover, we call this for ease of reference the chronic fraction. We 
examined subgroups based on several known determinants or risk factors, 















 and history of 
depression.
2,4,6,7 
In this work we establish a method by which the random-
mood parameters, Z and T, can be evaluated for different risk factor-based 
subcohorts. The data are organized as survival curves: the percentage of 
persisting MDDs in a cohort plotted versus the time elapsed since their 
onset. We show that survival curves of the more homogeneous risk factor-




Figure 1: Mood curve, generated with the random-mood model, as it could 
be for an arbitrary individual from the general population. The parameters 
are those for the full NEMESIS cohort : D=120 days, <T>=365 days, Z=1, 
and depression line=x2 munits (broken line). 
 
 
fraction plus a constant rest group, similar to the full cohort. The adopted 
procedure is then used to calibrate simulated random-mood survival curves 
against exponential decay and to establish their dependence on Z and T. 
The results show that: (1) Z may be identified with a risk ratio of the 
depressed cohort and the general population; and (2) the mean duration 
of an MDD episode is, apart from a constant, found as the product of Z and 
T. This Z–T analysis is compared with commonly used tools such as the log 
rank test and the hazard ratio, and conclusions regarding our current 





Description of the cohort and subgroups  
 
The data are from NEMESIS
9
, a prospective psychiatric epidemiological 
study in the Dutch adult population (7076 subjects, age 18–64 years)  
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selected household, one (non-depressive) respondent was chosen  
randomly; 4796 respondents were examined at all three waves with the 





used for psychiatric diagnoses. New episodes of major depression (first or 
recurrent) were found in 273 subjects. Inclusion criteria were: diagnosis of 
an MDD episode between T1 and T2 but no diagnosis of 1-month  
revalence between T0 and T1. Only first MDD episodes between waves 2 
and 3 were used, excluding bipolar disorder and primary psychotic disorder. 
Using the Life Chart Instrument,
24
 the duration of major depressive 
episodes was assessed retrospectively in 250 subjects and discretized into 
1.5-month intervals. Recovery was defined as no or minimal depressive 
symptoms in 3 months. In the present work we studied subgroups for six 
variables: severity of depression, defined as mild or moderate versus 
severe based on DSMIII- R criteria; co-morbid anxiety disorder, defined as 
having had any DSM-III-R anxiety disorder between T1 and T2 ; co-morbid 
dysthymia, defined as having had DSM-III-R dysthymia between T1 and T2; 
somatic comorbidity, defined as the presence of one or more conditions 
from a list of 31 somatic disorders for which the subject was treated or 
monitored by a doctor in the last year before wave 1; history of depression, 
defined as first versus recurrent episodes; and gender. Details on the 
random-mood model, survival analysis and significance tests are provided 





Relationship between exponential decay and the random-mood model 
 
Figure 2(a) shows the survival data for the full NEMESIS cohort, compared 
with exponential decay and a random-mood curve, both in combination with 
a 20% chronic fraction. The random-mood parameters in this calculation 
are
11
: (1) mean time lapse between successive stimuli, D=120 days; (2) 
depression level=x2 munits; (3) Z=1; and (4) T=365 days, the mean of the 
Poisson distribution, from which relaxation times are taken. Z and T are 
obviously individual or group characteristics. To investigate how these  
influence the mean duration of an MDD, we ran the random-mood program 
on a grid of Z–T values to produce high-statistics simulated survival curves. 
D was kept at 120 days and the depression level at -2 munits, thus keeping 
the stressor pattern unchanged. The resulting curves were subject to a fit 
with single exponential decay to determine the decay time, t, which at the 
same time is the mean duration. Based on the near-exponential form of the 
random-mood curves, an approximate empirical scaling is found, as  
illustrated in figure 2(b), where mean duration has been plotted versus the 
product ZT. The points cluster around a straight line, at least for ≤ 6  
months. As the duration is no longer for any of the subgroups, we have: 
 










For the full cohort, ZT=12 months and the decay time is τ=3.71 months. 
This fixes the proportionality constant: 
 
 
ZT = (12/3.71)τ = 3.235τ,     (1) 
 
which corresponds to the solid line in figure 2(b). Another empirical scaling 
is observed:  
 
Scaling rule B: Incidence (depressions/year/person) is  proportional to Z, 
independent of T  
 
A simple example illustrates how Z is determined by use of this scaling rule  
in the general population, the numbers of men and women are about equal 
and the probability that a randomly picked individual will be a man or a  
woman is approximately one-half for both. In the depressed cohort,  
however, the number of women is about twice that for men. Evidently, the 
probability that a randomly picked subject, known to be depressed, will be a 
man is P(man
D
) ≈ 1/3 and the probability of being a woman,  
P(woman
D
) ≈ 2/3. The average susceptibility of the general population can 
be defined as Z = 1. It follows that Z(man) ≈ (1/3) / (1/2) = 2/3 and  
Z(woman) ≈ (2/3) / (1/2) = 4/3. This identifies Z as the risk ratio (RR), or 
likelihood ratio, for identifying an individual as belonging to a certain  
determinant-defined subgroup, when comparing a depressed cohort with 
the general population. The same procedure can be followed for other 
determinants. In this work we evaluate Z as the ratio for the depressed 
NEMESIS cohort (n=250, recoverable cases only) and wave 1 (n=7076) of 
the same study. The above man/woman example discloses a small  
ambiguity: the mean susceptibility of the full depressive cohort would be 
<Z> = (1/3)(2/3)+(2/3)(4/3)=10/9=1.11, rather than Z=1, with which it was 
analysed. This is not surprising, as the mean susceptibility of a depressed 
cohort may be expected to be larger than that of the general population. By 
scaling rule A, the identical mean duration is then obtained by adopting 
T=(9/10)12=10.8 months. In practice, depending on the bipartition that is 
chosen, <Z> will always be slightly larger than 1, with statistical spread due 
to the finiteness of the sample. For some determinants it is impossible to 
give a priori probabilities. An example is severe/nonsevere, a distinction  
that can only be made when the depression already exists. Instead of 
dropping the analysis altogether, we prefer to proceed on a working  
assumption, for which we adopt Bayes‟ postulate of equal a priori 




In the particular case of severe/non-severe, this means taking both as 50%. 
In summary, we have made the important identification: 
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Figure 2: (a) Survival curve of the full NEMESIS cohort, compared with an 
exponential decay fit (broken line) and with the random-mood model (solid 
line), both for an 80% recoverable fraction. The 20% long-term fraction, F, 
has been modeled as constant. The random-mood parameters are those 
for the general population and are the same as in Fig. 1. (b) Decay times 
obtained from random-mood simulated survival curves (vertical) plotted 
versus the product ZT. The solid line indicates the empirical scaling rule A. 
 
 
Once Z is known, T is obtained by using scaling rule A and equation (1). 
Hence, these two scaling rules allow for separate estimates of Z and T, 
which are found to be group-typical parameters. 
 
Parametric fits of subgroup survival functions 
 
The survival function is taken as a two-parameter form that assumes a 
chronic fraction F and a reversible part (1 – F), with mean duration τ. 
 









This may be considered as a limiting case of a double-exponential form,  
where the second decay time is long enough to make the last term almost 
constant over the follow-up time. In this form it is similar to multi-exponential 




 Modelling the long-
term depressive fraction as constant reduces the number of adjustable 
parameters to just the mean duration, τ, of the recoverable fraction and the 
size of the chronic fraction, F. Fitting is done by maximizing the likelihood 
function, which we take in the form as used by Kaplan & Meier.
28
 Survival 
curves for the different subgroups are shown in figure 3(a), along with their 
fits. The fit parameters and their standard deviations are given in table 1, 
along with the random-mood parameters, Z and T, that follow from scaling 
rules A and B. Figure 3(b) shows a two-by-two comparison of the 95% 
confidence contours (CCs) for the subgroups that are being contrasted, 
drawn in the plane of τ and F. From a visual inspection of their distances 
and the lack of overlap of their CCs, significance is immediately apparent  
for the risk factors severity, recurrence and dysthymia. 
 
Survey of the significance tests 
 
Various methods exist for testing the null hypothesis, that two different 
survival curves might result from a common underlying mechanism. Two 
commonly used statistics are the log rank test and the hazard ratio (HR), 
which is the output of a univariate Cox regression. Both log rank and HR 
are χ
2
 (df=1) statistics. In addition, we use a parametric test, based on 
the differences in the fit parameters τ and F. This statistic, which we denote 
as W
2
, is judged against a χ
2
 (df=2) distribution. Its precise definition, along 
with a brief description of log rank and HR, is given in the Appendix. The 
results for these three test statistics are listed in table 2. All three tests 
indicate that the probability for the null hypothesis to be true is outside the 
95% confidence interval (CI) for the following cases: (1) non-severe/severe, 
(2) non-recurrent/recurrent and (3) dysthymia/ no dysthymia. For the 
women/men subgroups the HR and the log rank are well within the 95% CI, 
but the parametric W
2
 test is close to the limit. All methods agree that the 
difference between somatic disease/no somatic disease is small enough to 
make the null hypothesis probable even inside the 63% CI. No anxiety/ 
anxiety is within the 95% CI for all three criteria. 
 
Z–T classification of risk factors 
 
Figure 4 shows a plot of Z versus τ. On the basis of the three criteria, log 
rank, HR and W
2
, the difference was found to be not or hardly significant 
for men/women, no somatic disease/ somatic disease and no anxiety/ 
anxiety. These criteria judge the difference between subgroups 
by the shape of their survival curves alone. When taking into account 
differences in incidence between the subgroups, as in the Z–T 
classification, very marked differences are evident; depressions in women 
are classified as high incidence/short duration, while in men they are of low 
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identical duration, but the incidence among subjects with co-morbid anxiety 
is more than two times the average of the general population and three 
times higher than for subjects without anxiety. For the subgroups with co-
morbid somatic disease/no somatic disease, the Z–T classification reveals 




































































Figure 3: (a) Survival curves for contrasted risk factor-defined subgroups. 
(b) 95% confidence contours (CCs) on the fit parameters of the contrasted 
groups. t is the mean duration for the reversible fraction (1xF) and F is the 
chronic fraction. Crosses indicate standard deviations on the individual 






The present work has demonstrated that survival curves for all subcohorts  
can be described by a chronic fraction, F, of typically 10–30%, and a 
reversible fraction (1 – F) that decays exponentially, its mean duration 
varying between 2.0 months (dysthymia) and 5.5 months (severe 
depression). We have established two empirical scaling rules, through 
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model and by which its parameters Z,susceptibility, and T, relaxation time, 
can be determined separately. Hence the random-mood model is found to 
work for all subcohorts, and each of them is characterized by its own group 
average values of Z and T. We have attempted to differentiate between 
the subgroups in three different ways: (1) by the conventional log rank and 
HR test ; (2) by differences in parametric fits, embodied in our W
2
 statistic 
and visual inspection of the 95% CCs [figure. 3(b)] ; and (3) by the Z–T 
classification, which concentrates on the non-chronic fraction and uses 
relative incidence as an additional tool. This Z–T classification appears to 
have a definite added value and brings out pronounced differences in men/ 
women and anxiety/ no anxiety, which the more conventional criteria do not 
or hardly detect. In the following sections we survey the current 
understanding of the three characteristics, chronicity, duration and 






















1.43 6.91±0.94 0.181±0.032 3.06±0.29 
Severe 30 50
c 





1.05 13.67±1.71 0.264±0.04 4.44±0.53 
Recurrent 43 50
c 
0.95 10.22±1.07 0.118±0.033 3.00±0.33 
No 
dysthymia 
90 97 0.97 13.05±1.07 0.154±0.027 3.93±0.33 
Dysthymia 10 3 1.74 3.76±1.94 0.520±0.100 2.03±0.60 
Men 33 47 0.73 22.15±2.43 0.172±0.050 5.00±0.75 




47 49 1.00 12.22±1.42 0.175±0.038 3.78±0.44 
Somatic 
disease 
53 51 1.00 11.78±1.33 0.224±0.040 3.64±0.41 
No 
Anxiety 
66 86 0.79 14.62±1.13 0.175±0.033 3.55±0.35 
Anxiety 34 14 2.37 2.37±1.91 0.245±0.049 4.09±0.59 
 
Table 1: Parametric analysis of the NEMESIS data and subgroups 
NEMESIS, The Netherlands Mental Health Survey and Incidence Study; Z, 
susceptibility (random-mood parameter), obtained from scaling rule B; T, 
relaxation time (random-mood parameter), obtained from scaling rule A; F, 
long-lasting (chronic) fraction ; τ, mean duration for recoverable fraction. 
A
Percentage of depressive NEMESIS cohort (n=250).  
B
A priori probability among the general population, estimated from wave 1 
(n=7076). 
C












 Hazard ratio test Log rank test Parametric test 
Subgroup 1/ 
subgroup 2 





Non-severe/severe 0.67 0.49–.89 0.001 7.47 0.006 7.7 0.021 
Non-
recurrent/recurrent 
1.63 1.26–.11 0.003 15.02 <0.001 13.0 0.002 
No 
dysthymia/dysthymia 
0.47 0.24–.79 <0.001 9.08 0.003 20.2 <0.001 




0.90 0.69–.16 0.395 0.64 0.424 0.84 0.657 
No anxiety/anxiety 0.81 0.61–.07 0.098 2.39 0.122 2.0 0.368 
 
 
Table 2: Significance tests for contrasted subcohorts 
HR, Hazard ratio ; CI, confidence interval. Log rank test: Mantel–Cox form 





All three test statistics judge the difference between these subgroups 
significant outside the 95%CI. The mean duration for the severe cases 
is much longer than for the non-severe cases: 5.56 versus 3.06 months. In 
addition, the risk that the depression will become long-lasting is larger 
in severe depressions. The random-mood Z–T classification finds that 
severe depressions are of long duration and non-severe depressions of 
short duration. As severity is measured by the number of symptoms at 







The difference between the survival curves of these groups is found outside 
the 95%CI for all three test statistics. Recurrent depressions have shorter 
duration than first depressions, 3.00 versus 4.44 months, while the  
probability of developing into a long-lasting depression is also smaller. It is 
not intuitively evident why recurrent depressions should be shorter than 
non-recurrent ones. Ormel et al.
30
 have suggested that such depressions 
could be due to general vulnerability. In the language of the random-mood 
model, this would suggest that the subject has high susceptibility and that 
consequently the stressors must have short relaxation times. We have 
based our Z–T classification on Bayes‟ postulate of equal a priori  
probabilities, resulting in the nearaverage values Z=0.95 and T=10.22 
months. Considering, however, that scaling rule A determines only their 
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At only 10% of the total cohort, the dysthymia subgroup has a very different 
signature: the chronic fraction is large (52%), but for the recoverable 
part, the duration is short (2.03 months). All three test statistics indicate that 
the survival curves are significantly different beyond the 95% CI. In terms of 
the Z–T classification, the recoverable part of the dysthymia group is 
characterized as of high susceptibility and short duration. Dysthymia is a 
prolonged state of low baseline mood, in which it meets a minimum 
number of inclusion criteria
12
 that are in common with those for MDD, but 
fewer in number. When the number of inclusion symptoms increases 
temporarily to above the diagnostics level of MDD, the dysthymic subject 
is said to have a double depression. This is the situation we are considering 
here. In a random-mood interpretation, dysthymia might be characterized 
as a state of reduced distance between baseline mood and depression 
level, which might then be triggered by small-amplitude stimuli. This 
hypothesis provides a natural explanation for the high susceptibility found in 
our Z–T classification (table 1, figure 4). It does not, however, without 
further assumptions, explain the very short duration of the recoverable 
depressive episodes (only 2.03 months). This short duration suggests that 
the stimuli themselves should have a reduced relaxation time, T. Both 
aspects might be explained by a „ selective response‟ scenario: a dysthymia 
patient might have (very) long relaxation times for strong negative stimuli, 
causing these to pile up to a negative level, which is, however, still  
subthreshold for MDD. For small negative stimuli the patient might then 
show „normal‟ responses. In addition, impairment between coping with 
positive and negative daily events, one of the inclusion criteria for  




No major differences in survival curves for men and women are found by 
the HR and log rank tests. The parametric W
2
 statistic is, however, at the 
edge of the 95% CI. The difference between men and women is even more 
evident from the Z–T classification: about two-thirds of the full cohort are 
women and one-third are men. This translates into a two-times higher 
susceptibility for women. Although the difference between men and women 
in their risk of becoming depressed is generally known, some studies find 
no significant difference in duration and chronicity
9,10,31,32
 while others do .
21
 
In hospitalized subjects, chronicity has been observed to be more frequent 
in women than in men.
16
 In our study we found only a slightly higher chronic 
fraction for women. However, the mean duration for the recovering cases is 
very different : 3.18 months for women versus 5.00 months for men. This is 
the more remarkable because the fraction of women with severe 
depression characteristics at baseline is 34% compared with only 23% 
for men [odds ratio (OR) 1.70, p=0.051]. Oldehinkel et al.
33
 suggested that 
women, once depressed, are better at putting positive life changes into 









cohort, the percentage of women with co-morbid anxiety disorder was 
significantly higher than for men: 39% versus 23% (OR 2.15, p=0.004). 
Recurrence was also found more frequently in women than in men (46% 
versus 36%, OR 1.50, p=0.094), unlike the results of the study by 
Eaton et al.
31
, who found no difference in recurrence. 
 
No somatic disease/somatic disease 
 
None of the three tested statistics indicates a significant difference between 
the two survival curves. Neither does the Z–T classification. This is not  
surprising because, for the most prevalent diseases included in the criterion 
list (hypertension, sinusitis, back pain and asthma), their possible  
association with depression has not been demonstrated. Diseases that are 
known risk factors
34
, such as cardiovascular disease, diabetes mellitus,  
AIDS/HIV, cancer and rheumatoid arthritis, account for less then 20% of the 
prevalence in the present subcohort. Even when assuming a 50% increase 
in duration in such cases, the net effect on the full subcohort will only be 
some 10%. This is in line with the observed 7% higher median duration 
of 3.76±0.54 months for the diseased group versus 3.52±0.49 months for 
the non-diseased subcohort and the 30% higher long-duration (chronic) 




The survival curves for no anxiety/anxiety do not differ significantly as 
judged by the log rank and HR criteria and by the W2 test. The Z–T 
classification, however, reveals a remarkable difference: anxiety is 
associated with a very high susceptibility for becoming depressed, by far 
the highest of all the risk factors investigated in this study. Several studies 
9,10,35
 have reported a negative effect of anxiety on the course of  
depression. Our investigation confirms this: we find that anxiety is more 
likely to lead to chronicity and also the duration for the recoverable cases is 
slightly higher. From subject numbers at baseline, anxiety is found to 
correlate strongly with co-morbid dysthymia (OR 2.76, p=0.013) and with 
gender, where it affects women more often then men (OR 2.15, p=0.004). 
In subjects with anxiety disorder, severe depression is observed almost 
twice as frequently as in subjects without anxiety (OR 2.49, p<0.001). 
These correlations suggest that anxiety may be viewed as an important 
cause of increased incidence and that it has an aggravating effect on 
severity. No significant correlation with recurrence was observed 
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Figure 4: Classification by susceptibility, Z, and mean duration, t. The 
numbers correspond to the subgroups shown in tables 1 and 2  
(1) total, (2) non-severe, (3) severe, (4) non-recurrent, (5) recurrent, 
(6) no dysthymia, (7) dysthymia, (8) men, (9) women, (10) no somatic 






Our present work further supports the conceptualization of depression as a 
response to randomly occurring stressors. It provides an explanation of how 
risk factor-defined groups of individuals may differ in their susceptibility and 
response time to stressors. A detailed analysis of survival data on  
depression, including data on relative incidence, has demonstrated the 
feasibility of evaluating the group-typical random-mood model parameters 
susceptibility and relaxation time and has established their connection 
with the easy-to-interpret observables risk ratio and mean duration. This Z–
T classification has definite merits: in the present work it highlights 
differences in incidence and in the typical time course of depression 
between men and women, and between subjects with and without co-
morbid anxiety, that have previously gone unnoticed. By combining 
information on incidence and duration for a given determinant, the Z–T 
classification differs from the Cox regression, which uses determinants to 


















Day-to-day mood sequences, ym, are generated by:
11 
 




The component gw(D) is gaussian white noise: stimuli randomly distributed 
in time with average spacing D. Z is the susceptibility and T the relaxation 
time. It is easiest to think of gw(D) as expressed in munits. Z is then just a 
number, which agrees with equation (2), where Z has been identified with a 
risk ratio. The random-mood simulation that matches the recoverable 
fraction of the full NEMESIS cohort is obtained by taking D=120 days, Z=1, 
relaxation times Poisson-distributed with mean <T>=365 days, and a 
depression line at -2 munits. 
 
Non-parametric estimates and significance tests 
 
At each follow-up inspection, numbered by k, we denote the number of 
subjects at risk as nk and those whose MDD episode has ended during the 
last interval, as mk. The model-independent estimate
28 
for the conditional 
probability that MDD will survive the kth interval, while already having 
lasted during all previous ones, is pˆk=(n k – m k)/ n k. Its complement is the 
hazard: ĥ k = mk /nk. Conventionally, circumflexes are used to indicate that 
these are non-parametric estimates, based directly on the data. The 
survival probability is evaluated as the product Ŝ k  = pˆ1pˆ2 ,…,pˆ k. It is 
also known as a time-to-event curve. In our case, the looked-for event is the 
end of an MDD episode. When comparing two different survival curves, the 
corresponding hazards are written as ĥjk = mjk/njk ( j=1, 2). The commonly 
used log rank test compares the total number of events in subgroup 1  
against the number expected if, instead of ĥ 1k = m 1k/n1k, which are the 
estimates of the first group on its own, the estimates of the combined group 
(m1k+m2k)/(n1k+n2k), would have been used. A univariate Cox regression 
assumes the hazards of the two groups to be just scaled versions of one 
another: h2k=Ah1k. The value of A for which this procedure gives the highest 
likelihood is called the hazard ratio (HR). Both the log rank and the hazard 
ratio only probe the global similarity or dissimilarity of two survival curves. 
For further details, the reader is referred to a text-book.
36 
 
Parametric significance test 
 
Survival curves are of the form: S(t) = (1-F) exp (-t/τ) + F. Consider fits for 
two subgroups, τ(1), F(1) and τ(2), F(2), and their standard deviations (SD). 
Differences between the curves may be judged by a properly weighted 
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) may be shown to follow a χ
2
 (df=2) 
distribution. We estimated the distribution correlation coefficient, r, from 
simulated random-mood data and found it to be very small: ρ ≈ - 0.017. 








(F) can serve as a χ
2
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